Clinical Trial Update: A Trial Using Molecular-Guided Therapy in Patients With Refractory or Recurrent Neuroblastoma

View source ↗

Summary

A completed clinical trial investigated molecular-guided therapy in patients with refractory or relapsed neuroblastoma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Neuroblastoma

Snippet

Sponsor: Giselle Sholler | Conditions: Refractory Neuroblastoma, Relapsed Neuroblastoma | Status: COMPLETED